Decreased susceptibility to cefepime/zidebactam among carbapenemase-producing <i>Escherichia coli</i> from Stockholm, Sweden with alterations in PBP2
Our results indicate that DS to cefepime/zidebactam among clinical isolates of E. coli could arise due to targeted mutations in PBP2.
Authors
- Christian G. Giske (ORCID: https://orcid.org/0000-0003-4327-6122)
- Chaitanya Tellapragada (ORCID: https://orcid.org/0000-0002-0117-5369)
- Patrik Jonsson
- Chantel Dunleavy
Institutions
- Karolinska University Hospital (SE)
- Karolinska Institutet (SE)
Publication Details
- Journal
- Journal of Antimicrobial Chemotherapy
- Published
- 2025-02-04
- DOI
- https://doi.org/10.1093/jac/dkaf045
- Citations
- 4
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 2.36